June 24, 2020 / 11:38 AM / 15 days ago

BRIEF-La Jolla Pharmaceutical Company To Acquire Tetraphase Pharmaceuticals

June 24 (Reuters) - Tetraphase Pharmaceuticals Inc:

* LA JOLLA PHARMACEUTICAL COMPANY TO ACQUIRE TETRAPHASE PHARMACEUTICALS, INC.

* LA JOLLA PHARMACEUTICAL COMPANY TO ACQUIRE TETRAPHASE PHARMACEUTICALS, INC.

* TETRAPHASE PHARMACEUTICALS INC - LA JOLLA AGREEMENT PROVIDES FOR $43.0 MILLION IN UPFRONT CASH

* TETRAPHASE PHARMACEUTICALS INC - LA JOLLA WOULD ACQUIRE TETRAPHASE, THROUGH A TENDER OFFER

* TETRAPHASE PHARMA - DEAL INCLUDES UPFRONT CASH PLUS POTENTIAL FUTURE CASH PAYMENTS OF UP TO $16.0 MILLION PURSUANT TO CONTINGENT VALUE RIGHTS

* TETRAPHASE PHARMACEUTICALS - TETRAPHASE EQUITY HOLDERS WOULD BE ENTITLED TO RECEIVE, FOR EACH SHARE OF TETRAPHASE STOCK, ONE NON-TRADEABLE CVR

* TETRAPHASE PHARMACEUTICALS - TETRAPHASE TERMINATED MERGER WITH MELINTA THERAPEUTICS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below